Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jeff Grotzke"'
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76801 (2013)
We have investigated the effect of different maturation stimuli on the ability of mature dendritic cells (DCs) to cross-present newly acquired particulate antigens. Cross-presentation was impaired in DCs matured by treatment with TNF-α, CpG and LPS,
Externí odkaz:
https://doaj.org/article/225a398c28904abebf7e34cc4a981ea9
Publikováno v:
Molecular Immunology. 150:28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f0f3e64203d98e3aef3dc0e5e43070a
https://doi.org/10.1016/j.molimm.2022.05.096
https://doi.org/10.1016/j.molimm.2022.05.096
Autor:
Sean Landrette, Tian Xu, Xuan Zhang, Jeff Grotzke, Neil Beeharry, Paul Beckett, Henri Lichenstein, Michael Andreeff, Peter R. Young, Bing Z. Carter, Stephanie Halene, Sophia Gayle, Jonathan M. Rothberg, Marylens Hernandez
Acute myeloid leukemias (AML) harboring a constitutively active internal tandem duplication (ITD) mutation in the FMS-like kinase tyrosine kinase (FLT3) receptor are associated with poor patient prognosis. Despite initial clinical responses to FLT3 k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77f15f537843aefbac50e2694a3e80ad
https://europepmc.org/articles/PMC6880894/
https://europepmc.org/articles/PMC6880894/
Autor:
Sean Landrette, Neil Beeharry, Peter Young, Henri Lichenstein, Langdon L. Miller, Jeff Grotzke, Jonathan M. Rothberg, Stephanie Halene, Marylens Hernandez, Sophia Gayle, Tian Xu
Publikováno v:
Blood. 134:2664-2664
Acute myeloid leukemia (AML) remains a disease with high unmet medical need. While most patients respond to initial therapy, few are cured, relapse rates are high, and most patients eventually develop life-threatening complications. FLT3-mutant disea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d0fd34c1a980d1f811853accf35fdaf
https://doi.org/10.1182/blood-2019-125770
https://doi.org/10.1182/blood-2019-125770